Mounjaro side effects: what the reviews and clinical evidence tell you

What clinical trials recorded, and how to read those numbers

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults with obesity over 72 weeks and remains the most detailed evidence base for tirzepatide's tolerability. Gastrointestinal effects were the dominant pattern: nausea, diarrhoea, vomiting, constipation, and indigestion were all more common with tirzepatide than placebo, but most were rated mild to moderate in severity. Importantly, discontinuation due to side effects was relatively low (around 4–7% depending on the dose) which tells you that the majority of people found the effects manageable enough to stay the course.

The mechanism makes the pattern predictable. Tirzepatide slows gastric emptying and acts on appetite-regulating pathways in the gut and brain; the stomach is processing food more slowly, which produces nausea especially if meals are too large or too rich. That's why many of the practical strategies (smaller portions, eating slowly, avoiding very fatty or spicy food in the early weeks) are grounded in how the medicine actually works, not just habit. The NHS's patient information page on tirzepatide covers these strategies alongside the full side effect list.

Reviews from people using the medicine in the UK broadly mirror trial findings: nausea and fatigue feature most in the early weeks; many people report the effects becoming background noise by week four or five. You can read a broader picture of weight loss and side effect reviews from Mounjaro users on our dedicated page.

The side effects that need medical attention, not just reassurance

Most Mounjaro side effects are unpleasant but not dangerous. A few are different, and recognising them matters. In January 2026, the MHRA issued a Drug Safety Update specifically for GLP-1 medicines, confirming acute pancreatitis as an infrequent but serious risk. The symptom to act on is severe, persistent stomach pain that spreads toward the back, with or without vomiting. That presentation needs same-day medical assessment, not a wait-and-see approach.

Other signs that warrant prompt attention: symptoms of a gallbladder problem (sharp upper-right abdominal pain, fever, or jaundice); signs of significant dehydration from prolonged vomiting or diarrhoea (feeling faint, barely urinating, confusion); and any allergic reaction such as swelling of the face, lips, or throat. If you've ever heard the injection site become unusually painful or swollen rather than just mildly tender, that's also worth a call to your prescriber rather than waiting for the next appointment.

The latest clinical safety updates on Mounjaro are worth checking if you want to stay across what the MHRA and regulators are monitoring. And if you're ever unsure whether your symptoms need attention, contact our team, details are on the support page and we're available seven days a week.

Side effects that come up in reviews but aren't always explained clearly

A few effects appear regularly in online discussions but don't always get a straightforward explanation. Hair shedding is one of them. It crops up in tirzepatide side effects reviews fairly often, and it tends to alarm people, understandably. The most likely explanation is telogen effluvium: a temporary disruption to the hair cycle triggered by rapid weight loss and calorie reduction rather than a direct drug effect. It usually resolves on its own. Our page on Mounjaro and hair loss in women goes into this in more detail.

Headaches also come up often, particularly in the first week at a new dose. They can reflect changes in food intake, hydration, or simply the body adjusting to a different hormonal environment. If yours are severe or unusual, it's worth describing them to your prescriber, and our page on what a Mounjaro headache typically feels like gives some practical context. Fatigue in the first week or two is also common, again tracking dose increases.

The other thing reviews sometimes surface is what gets called "Mounjaro face", a loss of facial volume associated with significant weight loss. It's not specific to tirzepatide; it happens with any meaningful weight reduction. It's cosmetic, not a medical concern, though it's a reasonable thing to raise with a prescriber if it affects you. For a fuller picture of the five most discussed Mounjaro side effects, we've covered each in plain terms.

Reporting side effects and where your prescriber fits in

If you experience a side effect, the first port of call is your prescribing team. At nume, that means our aftercare line, available every day of the week, because side effects don't schedule themselves around Monday morning. For unexpected or serious effects, the MHRA's Yellow Card reporting scheme is open to patients as well as clinicians, and reports from real-world users genuinely feed into safety monitoring. Mounjaro carries a Black Triangle (▼) status, meaning it's subject to additional MHRA surveillance, which is precisely why reporting matters.

A prescriber's job at the start of treatment isn't just to hand over a pen. It's to go through your health history, flag anything that might make certain side effects more likely, and agree a plan for what to do if they land hard. That's part of the consultation at nume, not an add-on. If you're considering treatment and want to talk through the side effect profile in the context of your own health, the right next step is to speak to our prescribers, it's a free consultation, reviewed the same day by a real clinician. You can also read more about how tirzepatide works and what to expect on our full Mounjaro side effects guide.